Hudlett Philippe, Neuville Agnès, Miternique Anne, Griffon Christophe, Weltin Denis, Stephan Dominique
Laboratoire de Recherche sur l'Angiogenèse, Faculté de Médecine, Université Louis Pasteur, 11 rue Humann, 67085 Strasbourg, France.
J Hypertens. 2005 Aug;23(8):1559-64. doi: 10.1097/01.hjh.0000174607.18780.62.
Microvascular rarefaction by an unbalanced angiogenesis could promote the onset of hypertension in spontaneously hypertensive rats and in hypertensive patients. We studied the angiogenic potency in the fibrin gel chamber model in prehypertensive spontaneously hypertensive rats and their controls, Wistar-Kyoto rats.
Four-week-old prehypertensive spontaneously hypertensive rats (n = 9) and Wistar-Kyoto rats (n = 9) were implanted with four fibrin gel chambers located in the dorsal subcutaneous space. After 14 days, vasculoconjunctive buds had invaded the fibrin gel through the 10 hole-perforated bottom slip of the chamber. The intact vascular buds were studied using optical microscopy, alpha-actin and von Willebrand factor stainings. Capillaries and arterialized vessels were counted in three peripheral and one central field in each bud. The immunodetection of vascular endothelial growth factor and fibroblast growth factor 2 was performed on the neovascular buds.
In fibrin chambers implanted in spontaneously hypertensive rats, the number of peripheral vessels was significantly higher than in Wistar-Kyoto rats. There were significantly more arterialized vessels in spontaneously hypertensive rats compared with Wistar-Kyoto rats. The number of immunostained cells for fibroblast growth factor 2 was significantly greater in spontaneously hypertensive rats compared with Wistar-Kyoto rats. There was no significant difference in vascular endothelial growth factor staining between the two strains of rats.
Angiogenesis and arteriogenesis are increased in fibrin chambers implanted in prehypertensive spontaneously hypertensive rats compared with Wistar-Kyoto rats. These results argue against microvascular rarefaction as a cause of hypertension using this model of angiogenesis.
血管生成失衡导致的微血管稀疏可促使自发性高血压大鼠和高血压患者发生高血压。我们在高血压前期自发性高血压大鼠及其对照Wistar-Kyoto大鼠的纤维蛋白凝胶腔模型中研究了血管生成能力。
将四周龄的高血压前期自发性高血压大鼠(n = 9)和Wistar-Kyoto大鼠(n = 9)在背部皮下植入四个纤维蛋白凝胶腔。14天后,血管连接芽通过腔室底部有10个孔的载玻片侵入纤维蛋白凝胶。使用光学显微镜、α-肌动蛋白和血管性血友病因子染色研究完整的血管芽。在每个芽的三个外周区域和一个中央区域计数毛细血管和动脉化血管。对新生血管芽进行血管内皮生长因子和成纤维细胞生长因子2的免疫检测。
在植入自发性高血压大鼠的纤维蛋白腔中,外周血管数量显著高于Wistar-Kyoto大鼠。与Wistar-Kyoto大鼠相比,自发性高血压大鼠的动脉化血管明显更多。与Wistar-Kyoto大鼠相比,自发性高血压大鼠中成纤维细胞生长因子2免疫染色细胞的数量显著更多。两株大鼠之间血管内皮生长因子染色无显著差异。
与Wistar-Kyoto大鼠相比,植入高血压前期自发性高血压大鼠的纤维蛋白腔中血管生成和动脉生成增加。这些结果与微血管稀疏是使用该血管生成模型导致高血压的原因这一观点相悖。